Aripiprazole

Overview

Aripiprazole is an atypical antipsychotic medication used primarily in the treatment of schizophrenia and bipolar disorder. It is notable for its unique mechanism of action that involves partial agonist activity at D2 dopamine and 5-HT1A serotonin receptors.

API suppliers (51)

Suppliers of Aripiprazole backed by a verifiable FDA Type II Drug Master File. Source: FDA quarterly DMF list.

• Qilu Pharmaceutical Co., Ltd.China2 active DMF
• APITORIA PHARMA PRIVATE LTDIndia2 active DMF
• Alembic Pharmaceuticals LimitedIndia2 active DMF
• Zakłady Farmaceutyczne Polpharma S.A.Poland2 active DMF
• Neuland Laboratories LimitedIndia2 active DMF
• INTERQUIM SA2 active DMF
• MATRIX PHARMACORP PRIVATE LTD2 active DMF
• MSN PHARMACHEM PRIVATE LTD2 active DMF
• Macleods Pharmaceuticals Ltd.India1 active DMF
• Zydus Lifesciences LimitedIndia1 active DMF
• ERREGIERRE SPAItaly1 active DMF
• CAMBREX CHARLES CITY INC1 active DMF
• COHANCE LIFESCIENCES LTD1 active DMF
• Apotex Inc.Canada1 active DMF
• ERREGIERRE SPAItaly1 active DMF
• CAMBREX CHARLES CITY INC1 active DMF
• ZHEJIANG JINHUA CONBA BIO-PHARM CO LTDChina1 active DMF
• Cadila Pharmaceuticals LimitedIndia1 active DMF
• WOCKHARDT BIO AG1 active DMF
• JUBILANT BIOSYS LTD1 active DMF
• Zydus Lifesciences LimitedIndia1 active DMF
• OLON SPAItaly1 active DMF
• TAPI NL BV1 active DMF
• Sun Pharmaceutical Industries LimitedIndia1 active DMF
• Apotex Inc.Canada1 active DMF

Showing 25 of 51 suppliers — see the full list in the app.

Patent & exclusivity (US)

Per the FDA Orange Book (117 approved US products), the latest listed US patent on Aripiprazole expires 15 Dec 2041. Generic API sourcing typically opens up once these lapse.

Therapeutic areas